188 related articles for article (PubMed ID: 32468468)
1. Synthesis, Molecular Docking Studies and Biological Evaluation of N-Acylarylhydrazones as Anti-Inflammatory Agents.
Devi TS; Rajitha G; Swathi K; Sudheer Kumar K; Umamaheswari A
Adv Exp Med Biol; 2020; 1195():137-148. PubMed ID: 32468468
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Cyclooxygenase-2 Inhibition, Anti-inflammatory Evaluation and Docking Study of Substituted-N-(3,4,5-trimethoxyphenyl)-benzo[d]oxazole Derivatives.
Kaur A; Wakode S; Pathak DP; Sharma V; Shakya AK
Med Chem; 2018; 14(7):660-673. PubMed ID: 29564981
[TBL] [Abstract][Full Text] [Related]
4. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX.
Omar YM; Abdu-Allah HHM; Abdel-Moty SG
Bioorg Chem; 2018 Oct; 80():461-471. PubMed ID: 29986191
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors.
Şenkardeş S; Han Mİ; Kulabaş N; Abbak M; Çevik Ö; Küçükgüzel İ; Küçükgüzel ŞG
Mol Divers; 2020 Aug; 24(3):673-689. PubMed ID: 31302853
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives.
Moraes ADTO; Miranda MDS; Jacob ÍTT; Amorim CADC; Moura RO; Silva SÂSD; Soares MBP; Almeida SMV; Souza TRCL; Oliveira JF; Silva TGD; Melo CML; Moreira DRM; Lima MDCA
Bioorg Med Chem; 2018 Nov; 26(20):5388-5396. PubMed ID: 30293795
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents.
Mohammed KO; Nissan YM
Chem Biol Drug Des; 2014 Oct; 84(4):473-88. PubMed ID: 24720475
[TBL] [Abstract][Full Text] [Related]
10. Exploring Anti-inflammatory Potential of Thiazolidinone Derivatives of Benzenesulfonamide via Synthesis, Molecular Docking and Biological Evaluation.
Bari SB; Firake SD
Antiinflamm Antiallergy Agents Med Chem; 2016; 15(1):44-53. PubMed ID: 27216235
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Arch Pharm (Weinheim); 2018 Jun; 351(6):e1800008. PubMed ID: 29741797
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents.
Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM
Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents.
Hassan GS; Abou-Seri SM; Kamel G; Ali MM
Eur J Med Chem; 2014 Apr; 76():482-93. PubMed ID: 24607877
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents.
Firke SD; Bari SB
Bioorg Med Chem; 2015 Sep; 23(17):5273-81. PubMed ID: 26277757
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA
Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755
[TBL] [Abstract][Full Text] [Related]
18. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
Abdelgawad MA; Labib MB; Abdel-Latif M
Bioorg Chem; 2017 Oct; 74():212-220. PubMed ID: 28865292
[TBL] [Abstract][Full Text] [Related]
19. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
[TBL] [Abstract][Full Text] [Related]
20. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.
Ghanim AM; Rezq S; Ibrahim TS; Romero DG; Kothayer H
Eur J Med Chem; 2021 Jul; 219():113457. PubMed ID: 33892270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
